MEC Plus Full List View

By pinki@katapult.biz / February 16, 2025

Modern Challenges and new options for B-cell NHL

Modern Challenges and new options for B-cell NHL

Eduardo Sotomayor, MD

Gynecologic Malignancies: Targeted Therapy-IO-Chemo Combinations

Gynecologic Malignancies: Targeted Therapy-IO-Chemo Combinations

Alexander B. Olawaiye, MD

Breast Cancer Update in Hormone Sensitive Breast Cancer

Breast Cancer Update in Hormone Sensitive Breast Cancer

Ingrid A. Mayer, MD, MSCI

Advances in Targeted Therapy in Lung Cancer

Advances in Targeted Therapy in Lung Cancer

Edgardo S. Santos, MD, FACP

Advances in Head and Neck Cancers Including Thyroid Malignancies

Advances in Head and Neck Cancers Including Thyroid Malignancies

Tanguy Seiwert, MD

Immunotherapy Session

Immunotherapy Session

Sanjiv Agarwala, MD; Pedro Barata, MD; Ahmed Zakari, MD; Pedro G. Solivan, MD

Solid Tumors: Gynecology, Prostate & GI Malignancies

Solid Tumors: Gynecology, Prostate & GI Malignancies

Thomas Herzog, MD; Ulka Vaishampayan, MD; Ahmed Zakari, MD

Lung Cancer Session

Lung Cancer Session

Pedro G. Solivan, MD; Edgardo S. Santos Castillero, MD, FACP; Luis E. Raez, MD, FACP, FCCP; Genelis Domingo, MD

Breast Cancer Session

Breast Cancer Session

Vicente Valero, MD; Luis Baez Vallecillo, MD; Noridza Rivera-Rodriguez, MD; Mariana Chavez-MacGregor, MD; Mohammad Jahanzeb, MD, FACP, FASCO

Managing Symptoms & Supportive Care

Managing Symptoms & Supportive Care

Jorge J. García, PharmD, MS, MHA, MBA, FACHE; Rosanna Rodriguez, PA-C; Mildred Flores, RN, PhD

Lung Targeted Therapies IN NSCLC: EGFR, ALK, and ROS1

Lung Targeted Therapies IN NSCLC: EGFR, ALK, and ROS1

Edgardo S. Santos, MD, FACP

Lung Targeted Therapies in NSCLC: RET, MET and EGFR/HER-2 exon 20

Lung Targeted Therapies in NSCLC: RET, MET and EGFR/HER-2 exon 20

Robert Ramirez, DO, FACP

Immunotherapy & Targeted Therapy in Melanoma

Immunotherapy & Targeted Therapy in Melanoma

Sanjiv Agarwala, MD

Immunotherapy in Lung

Immunotherapy in Lung

Luis E. Raez, MD, FACP, FCCP

Breast Targeted Therapy: HER2, CDK 4/6, PI3KCA

Breast Targeted Therapy: HER2, CDK 4/6, PI3KCA

Mark Pegram, MD

MEDPRO™ Talk: A Patient’s Perspective

MEDPRO™ Talk: A Patient’s Perspective

Shannon Baxter, PhD

Immunotherapy in Breast

Immunotherapy in Breast

Alberto Montero, MD, MBA, CPHQ

Immunotherapy in Kidney & Bladder

Immunotherapy in Kidney & Bladder

Pedro Barata, MD, MSc

Targeted Therapy in Prostate

Targeted Therapy in Prostate

Ulka Vaishampayan, MD

Small cell and Squamous Cell Lung Cancer

Small cell and Squamous Cell Lung Cancer

Goetz Kloecker, MD MSPH MBA

Renal Cell Cancer Updates

Renal Cell Cancer Updates

Brian Rini, MD

Prostate and Bladder Cancer Updates

Prostate and Bladder Cancer Updates

Guru P. Sonpavde, MD

Melanoma and Skin Cancer Updates

Melanoma and Skin Cancer Updates

Meredith McKean, MD

Lung Adenocarcinoma Updates

Lung Adenocarcinoma Updates

Melissa L. Johnson, MD

Gastric, Esophagael, and Circulating Tumor Cells in GI Cancers

Gastric, Esophagael, and Circulating Tumor Cells in GI Cancers

Pashtoon Kasi, MD, MS

Drug Brown and White Bagging: What is It and Where Does it Lead Us?

Drug Brown and White Bagging: What is It and Where Does it Lead Us?

Jorge J. García, PharmD, MS, MHA, MBA, FACHE

Breast Cancer Update in Triple Negative and HER2 Breast Cancers

Breast Cancer Update in Triple Negative and HER2 Breast Cancers

Stephanie L. Graff, MD

Breast Cancer Update in Hormone Sensitive Breast Cancer

Breast Cancer Update in Hormone Sensitive Breast Cancer

Ingrid Mayer, MD

CRC Updates

CRC Updates

Cathy Eng, MD

Biosimilars as Front-Line Options for Cancer Care

Biosimilars as Front-Line Options for Cancer Care

Jorge J. García, PharmD, MS, MHA, MBA, FACHE